Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S) trial: Comparison of a sequential treatment with irinotecan (CPT-11) plus 5-fluorouracil (5-FU)/folinic acid (LV) followed by docetaxel and cisplatin versus a 5-FU/LV regimen as postoperative treatment for radically resected gastric cancer.Emilio Bajetta, R. Casaretti, E. Pasquini et al.|Journal of Clinical Oncology|2012Cited by 15
Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S) trial: Comparison of a sequential treatment with irinotecan (CPT-11) plus 5-fluorouracil (5-FU)/folinic acid (LV) followed by docetaxel and cisplatin versus a 5-FU/LV regimen as postoperative treatment for radically resected gastric cancer.Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo et al.|Journal of Clinical Oncology|2012Cited by 8
Phase II trial of paclitaxel (P) and cisplatin (COOP) in patients with advanced breast cancer refractory to anthracycline (A) therapyFerdinando Riccardi, G Pacilio, G. Rosati et al.|European Journal of Cancer|1997Cited by 1
A phase II study of alternating cycles of CPT-11 and high-dose 48 hour infusion 5-FU in combination with leucovorin (HD-5-FU/LV) in no selective patients with metastatic colorectal cancer (MCRC)G. Rosati, Luigi Manzione, Domenico Bilancia et al.|European Journal of Cancer|1999Cited by 0